Literature DB >> 28991939

PURLs: When to "CAP" off treatment for pneumonia.

Gregory Castelli1, Jennie B Jarrett2.   

Abstract

Prescribe 5 days of antibiotic treatment for inpatients with community-acquired pneumonia because it produces the same clinical success rates as longer treatment regimens, but is associated with fewer negative patient outcomes.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28991939      PMCID： PMC5659803     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

Review 1.  Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.

Authors:  Thomas M File
Journal:  Clin Infect Dis       Date:  2004-09-01       Impact factor: 9.079

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis.

Authors:  Jonathan Z Li; Lisa G Winston; Dan H Moore; Stephen Bent
Journal:  Am J Med       Date:  2007-09       Impact factor: 4.965

4.  Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.

Authors:  D Guillemot; C Carbon; B Balkau; P Geslin; H Lecoeur; F Vauzelle-Kervroëdan; G Bouvenot; E Eschwége
Journal:  JAMA       Date:  1998-02-04       Impact factor: 56.272

5.  Costs associated with shorter duration of antibiotic therapy in hospitalized patients with mild-to-moderate severe community-acquired pneumonia.

Authors:  B C Opmeer; R El Moussaoui; P M M Bossuyt; P Speelman; J M Prins; C A J M de Borgie
Journal:  J Antimicrob Chemother       Date:  2007-09-07       Impact factor: 5.790

6.  Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.

Authors:  Ane Uranga; Pedro P España; Amaia Bilbao; Jose María Quintana; Ignacio Arriaga; Maider Intxausti; Jose Luis Lobo; Laura Tomás; Jesus Camino; Juan Nuñez; Alberto Capelastegui
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873

7.  Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia.

Authors:  S Aliberti; F Blasi; A M Zanaboni; P Peyrani; P Tarsia; S Gaito; J A Ramirez
Journal:  Eur Respir J       Date:  2009-11-19       Impact factor: 16.671

8.  Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis.

Authors:  George Dimopoulos; Dimitrios K Matthaiou; Drosos E Karageorgopoulos; Alexandros P Grammatikos; Zoe Athanassa; Matthew E Falagas
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.